Supplemental material
Future Oncology
Volume 20, 2024 - Issue 6
Short Communication
Real-World Treatment Patterns, Survival, Health Resource use and Costs Among Medicare Beneficiaries with Diffuse Large B-Cell Lymphoma
Mahek Garg1 Merck & Co., Inc., Rahway, NJ07065, USA
https://orcid.org/0000-0003-2479-555X
https://orcid.org/0000-0003-2479-555X, Justin Puckett2 COVIA Health Solutions, Lansdale, PA19446, USAhttps://orcid.org/0000-0002-5135-7216
https://orcid.org/0000-0002-5135-7216, Sachin Kamal-Bahl2 COVIA Health Solutions, Lansdale, PA19446, USACorrespondence[email protected]
https://orcid.org/0000-0001-7559-3216
https://orcid.org/0000-0001-7559-3216, Monika Raut1 Merck & Co., Inc., Rahway, NJ07065, USAhttps://orcid.org/0009-0000-9538-2934
https://orcid.org/0009-0000-9538-2934, Katherine Elizabeth Ryland1 Merck & Co., Inc., Rahway, NJ07065, USAhttps://orcid.org/0009-0001-1749-7880
https://orcid.org/0009-0001-1749-7880, Jalpa A Doshi3 Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA19104, USAhttps://orcid.org/0000-0002-3263-4337
https://orcid.org/0000-0002-3263-4337 & Scott F Huntington4 Department of Internal Medicine, Section of Hematology, Yale University School of Medicine, New Haven, CT06510, USAhttps://orcid.org/0000-0001-7071-6475
https://orcid.org/0000-0001-7071-6475 show all